P27KIP1 and p16INK4A are recognized for their ability to arrest tumor cells in the G1 phase by interfering with the activities of CDKs, which play key roles in G1/S transitions (Witkiewicz et al., 2022). Here, CDKN2A is linked to neoplasm.